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and later confirmed by dosages of catecholamines. The institution
of an early aggressive treatment was life saving.
Compared with the scheduled device implantation in patients
deteriorating on the waiting list, management of emergencies
requiring circulatory support is still a challenging situation. We
have developed in our unit a mobile kit of emergency circulatory
support to deal with this problem. This ECLS has become a useful
adjunct to our cardiac assist device program, allowing patient
transfer and secondary implantation of a more long-term sophis-
ticated device.
As expected in this catecholamine-induced cardiomyopathy,
the patient recovered after surgical resection of the tumor, but
recovery is not so fast as to allow the use of an ECLS device alone,
and implantation of a long-term device was mandatory.
Conclusion
Diagnosis and treatment of cardiogenic shock caused by pheochro-
mocytoma is difficult and can end in fatal evolution. This case
emphasizes the need for an early aggressive treatment to improve
the outcome of this surgically curable pathology.
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Percutaneous occlusion of a pseudoaneurysm evolving after homograft
aortic valve and root replacement with the Amplatzer muscular
ventricular septal defect occluder
Eric M. Graham, MD,a Varsha M. Bandisode, MD,a Andrew M. Atz, MD,a Charles H. Kline, RDMS,a
Marian H. Taylor, MD,b and John S. Ikonomidis, MD, PhD,c Charleston, SC
Aortic root replacement with aortic homograft hasyielded good results in appropriate patients. Aorticpseudoaneurysms are a rare postoperative complica-tion, potentially leading to reoperation with signifi-
cantly higher surgical mortality.1 We describe a case in which a
left ventricular outflow tract pseudoaneurysm is successfully oc-
cluded with transcatheter device closure in a patient at high risk for
reoperation.
Clinical Summary
A 40-year-old woman presented with a history of a bicuspid aortic
valve with severe insufficiency, ascending aortic aneurysm, and hemi-
arch aneurysm. After discussion of the various treatment options, she
underwent surgical replacement with a 22-mm homograft aortic
valve, root, and ascending aorta. Her midterm postoperative course
was complicated by gram-negative endocarditis and dehiscence of the
homograft. Her aortic homograft was rereplaced 22 days after initial
intervention and was complicated by uncontrollable bleeding from a
posterior annular suture line. An anterior pericardial baffle was cre-
ated and decompressed to the right atrial appendage, resulting in
hemostasis. At 48 days after the second surgical intervention, fol-
low-up revealed a persistent and increasing left-to-right shunt. At
surgical re-exploration, an unsuccessful attempt (caused by continued
bleeding) was made to repair the homograft at the posterior annulus,
requiring replacement of the pericardial baffle.
Serial computed tomographic angiography revealed closure of
the left-to-right shunt, but a contained pseudoaneurysm remained
in the lateral aspect of the left ventricular outflow tract directed
posteriorly between the left atrium and the aortic arch and draped
by the left main coronary artery. Serial evaluations revealed pro-
gressive enlargement of the pseudoaneurysm with tenting of the
left main coronary artery at its bifurcation.
Given her multiple reoperations, she was referred for transcath-
eter device occlusion of the pseudoaneurysm. Institutional review
board approval for compassionate use of the device, as well as
informed consent, was obtained. Transthoracic echocardiography
revealed a 3.5  1.6–cm pseudoaneurysm located posteriorly and
leftward of the aortic valve. The neck to the pseudoaneurysm
originated under the aortic valve within the left ventricular outflow
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tract. The distance between the homograft aortic valve, the anterior
mitral leaflet hinge point, and the neck of the pseudoaneurysm was
6 and 7 mm, respectively.
A right and left heart catheterization was performed by using
the right femoral vein and artery, respectively with selective an-
giography of the left ventricle, aortic root and coronary arteries. A
5F 100-cm JR 3.5 catheter (Cook, Bloomington, Ind) was ad-
vanced retrogradely from the femoral artery into the left ventricle,
and the pseudoaneurysm was engaged. Angiography of the pseu-
doaneurysm revealed the neck measured 3.5 mm in diameter, with
tenting of the left main coronary artery (Figure 1). Standard device
delivery sheaths provided inadequate length for stable sheath
placement and device deployment. An 8F SL2 transseptal sheath
(St Jude Medical, Inc, Minnetonka, Minn) was loaded with a 7F IB
catheter (Boston Scientific, Natick, Mass), with stable position in
the pseudoaneurysm. A 4-mm Amplatzer muscular ventricular
septal defect occluder device (AGA Medical, Golden Valley,
Minn) was placed in the neck of the pseudoaneurysm with trans-
esophageal echocardiographic guidance. The distal disk was de-
ployed in the aneurysm, and the device waist was deployed in the
aneurismal neck. The proximal disk was deployed on the ventric-
ular aspect of the subvalvar aortic root. Obliteration of blood flow
into the pseudoaneurysm was noted by means of echocardiography
and angiography (Figure 2). No change in aortic or mitral valve
function was observed. The postprocedure recovery was unevent-
ful, with extubation in the catheterization laboratory, an overnight
observation, and subsequent discharge the following morning
without complications. Transthoracic echocardiography and com-
puted tomographic angiographic studies performed 1 month after
the procedure confirmed complete occlusion of the pseudoaneu-
rysm with resolving hematoma, no change in aortic or mitral valve
function, and no residual tenting of the left coronary artery.
Discussion
Pseudoaneurysm formation after aortic root replacement is a postop-
erative complication that has traditionally been addressed by surgical
means. Reoperation increases both the difficulty for exposure of the
surgical field caused by scar tissue and surgical mortality.
Reports of percutaneous occlusion of aortic aneurysms have
been described by using balloon occlusion to facilitate elective
surgical repair2 and coil embolization.3,4 The recent success with
an Amplatzer septal occluder device in a pulmonary aneurysm in
a patient with tetralogy of Fallot and Eisenmenger syndrome
confirms the utility of device closure in patients unsuited to stan-
dard surgical intervention.5 We describe an unconventional use of
the Amplatzer muscular ventricular septal defect occluder device
for transcatheter closure of an aortic pseudoaneurysm with mini-
mal risk and early complete closure.
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Figure 1. Left ventricular pseudoaneurysm with draping Left Cor-
onary Artery.
Figure 2. Complete occlusion of pseudoaneurysm with Amplatzer
Muscular Occluder Device.
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Congenital bronchoesophageal fistula in an adult woman
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Angel Gayete, MD, PhD,c and José M. Sánchez-Ortega, MD, PhD,a Barcelona, Spain
Tracheoesophageal or bronchoesophageal fistula (T/BEF),the abnormal communication between the esophagusand the tracheobronchial tree, may present at any timeduring the life span. In the neonate, T/BEF is a congen-
ital malformation associated with some form of esophageal atresia
in the vast majority of cases.1,2 Later in life, most T/BEFs are
acquired.3,4 However rare, if the congenital T/BEF is not associ-
ated with esophageal atresia, it may remain silent until it eventu-
ally becomes symptomatic. Herein, we report the clinical case of a
53-year-old woman whose congenital T/BEF was diagnosed and
treated at our institution.
Clinical Summary
The patient was referred to us as a result of a self-limited episode
of minor hemoptysis of sudden onset. At anamnesis, she explained
that she had experienced a pain in the upper abdomen 2 years
before. Gallbladder stone disease and unilateral renal agenesia
were diagnosed by echography, and chronic gastritis was diag-
nosed by esophagogastroscopy. She was then cholecystectomized
without postoperative complications. She did not disclose any
other previous disease or complaint. Physical examination was
normal on admission. Red blood cell, white blood cell, and platelet
counts, coagulation profile; routinary serum; and urine analysis
results were all within the normal range. Chest radiography and a
computed tomographic scan of the thorax displayed an irregular
area of lung parenchyma condensation in the upper segment of the
left lower lobe. On fiberoptic bronchoscopy, the tracheobronchial
tree was normal except for the presence of a blood clot that partly
occupied the lumen of the left lower lobe bronchus. Bronchial
washing specimens were sent for cytologic analysis, Gram and
acid-fast stain, and bacterial and mycobacterial culture; all yielded
negative results. Esophagogastroduodenoscopy revealed the pres-
ence of a double hole in the left wall of the middle esophagus.
Bouts of cough ensued every time the holes were instilled with
serum saline, thus establishing the diagnosis of T/BEF. Initial
treatment consisted of full oral fasting and total enteral nutrition
for 3 weeks. Then, an attempt was made to close the fistula by
endoscopic instillation of fibrin glue. However, an esophagogram
showed the persistence of the T/BEF (Figure 1), and the patient
was scheduled for an open surgical procedure. Dissection of the
fistula, closure of both ends with an automatic stapler, division of
the tract, handmade reinforcement of both sutures, and interposi-
tion of a pedicled pleural flap were performed through a left
posterolateral thoracotomy. Postoperative evolution was normal. A
second esophagogram showed no spilling of the contrast. The
patient restarted oral feeding on the sixth postoperative day.
Comment
Congenital T/BEF seldom presents in adulthood because it is
rarely left undiagnosed in the neonate: it is often associated with
some other bronchopulmonary and/or foregut malformation
(mainly with esophageal atresia).1,2 It is only in the absence of this
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Figure 1. Preoperative esophagogram. The contrast medium
passes from a diverticulum in the middle esophagus through an
ascending fistula to the left lower lobe bronchus.
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